Glucokinase Activator-based Solutions for Diverse Industries

Publication ID: 24-11857536_0007_PTD

Published: October 28, 2025

Category:New Applications & Use Cases

Legal Citation

pr1or.art Inc., “Glucokinase Activator-based Solutions for Diverse Industries,” Published Technical Disclosure No. 24-11857536_0007_PTD, Published October 28, 2025, available at https://archive.pr1or.art/24-11857536_0007_PTD

This technical disclosure describes improvements that would be readily apparent to a Person Having Ordinary Skill In The Art (PHOSITA) when considered in combination with the foundational architecture disclosed in U.S. Patent No. 11,857,536.

Summary of the Inventive Concept

This inventive concept expands the application of glucokinase activators beyond diabetes treatment to address pressing challenges in agriculture, livestock, environmental monitoring, animal health, and human performance.

Background and Problem Solved

The original patent focused on treating diabetes in renally impaired subjects using glucokinase activators. However, the limitations of this approach become apparent when considering the broader potential of glucokinase activators in addressing various industries' unmet needs. This inventive concept addresses these limitations by exploring new applications and use cases for glucokinase activators.

Detailed Description of the Inventive Concept

The inventive concept comprises a system for predicting and preventing agricultural crop failures by leveraging glucokinase activators to enhance soil moisture sensing. Additionally, it includes a method for optimizing livestock feed formulations using glucokinase activators to improve nutrient uptake in animals with impaired renal function. Furthermore, it encompasses a device for monitoring and controlling water quality in aquatic ecosystems, utilizing glucokinase activators to detect changes in water pH levels. The inventive concept also involves a method for treating and preventing neurological disorders in animals by administering glucokinase activators to enhance cognitive function and memory. Lastly, it incorporates a system for improving exercise performance in athletes, combining glucokinase activators with wearable devices for monitoring physiological parameters.

Novelty and Inventive Step

The new claims introduce a paradigm shift in the application of glucokinase activators, moving beyond diabetes treatment to tackle diverse industry-specific challenges. The inventive step lies in recognizing the potential of glucokinase activators to address unmet needs in agriculture, livestock, environmental monitoring, animal health, and human performance.

Alternative Embodiments and Variations

Alternative embodiments of the inventive concept could include using glucokinase activators in precision agriculture for real-time soil monitoring, developing personalized livestock feed formulations based on individual animal needs, or creating implantable devices for continuous water quality monitoring. Variations could also involve adapting the glucokinase activator-based system for monitoring and controlling air quality or using it in bioremediation applications.

Potential Commercial Applications and Market

The inventive concept has significant commercial potential in various industries, including agriculture, livestock, environmental monitoring, animal health, and human performance. The target market includes companies developing precision agriculture solutions, livestock feed manufacturers, environmental monitoring organizations, animal health companies, and sports technology firms.

Section 103 Obviousness Analysis (PHOSITA)

▼

Field of Art

Pharmaceutical biotechnology, metabolic disorder treatment, and medical device technologies with expertise in glucokinase activation, renal impairment interventions, and physiological parameter monitoring

Person of Ordinary Skill (PHOSITA) Profile

A professional with advanced degrees in biochemistry, pharmacology, or biomedical engineering, possessing knowledge of metabolic pathways, drug delivery systems, and interdisciplinary applications of enzyme modulators

Obviousness Rationale

A PHOSITA would recognize that the source patent's fundamental teaching of glucokinase activators for treating metabolic disorders provides a clear technological foundation for exploring broader applications. The PTD's variations represent predictable extensions of known glucokinase activation principles, applying the core mechanism to diverse domains like agriculture, environmental monitoring, and performance optimization. These applications leverage the established understanding of glucokinase's role in metabolic regulation, demonstrating systematic technological adaptation rather than inventive breakthrough.

Obvious Combinations & Variations

Source Patent Element

Method of treating glucokinase-mediated disorders in renally impaired subjects

PTD Variation

Optimizing livestock feed formulations using glucokinase activators to enhance nutrient uptake in animals with impaired renal function

Obviousness Reasoning

Known technique of applying metabolic modulators across species, predictable result of improving physiological performance through enzymatic intervention

Source Patent Element

Glucokinase activator for managing metabolic disorders

PTD Variation

Monitoring water quality using glucokinase activators as biosensing mechanisms for pH level detection

Obviousness Reasoning

Established principle of using enzyme-based detection systems, finite set of known biosensing applications in environmental monitoring

Source Patent Element

Treatment method targeting metabolic and physiological processes

PTD Variation

Improving exercise performance by integrating glucokinase activators with wearable physiological monitoring devices

Obviousness Reasoning

Predictable combination of known metabolic enhancement techniques with existing performance tracking technologies

Source Patent Element

Diabetes treatment targeting metabolic pathway regulation

PTD Variation

Neurological disorder treatment method using glucokinase activators to enhance cognitive function

Obviousness Reasoning

Known neurometabolic interactions, established scientific understanding of enzymatic modulation's potential cognitive impacts

Source Patent Element

Method of managing metabolic disorders through enzymatic activation

PTD Variation

Agricultural crop failure prediction using glucokinase activators for soil moisture sensing

Obviousness Reasoning

Predictable application of metabolic sensing principles to agricultural monitoring, finite set of known biosensing adaptation strategies

35 U.S.C. § 103 Summary: Pursuant to 35 U.S.C. § 103, the variations disclosed in this publication would have been obvious to a person having ordinary skill in the art at the time of invention, given the teachings of US Patent 11857536. The systematic extension of glucokinase activator principles across diverse technological domains represents a predictable application of known metabolic modulation techniques, rendering potential claims of novelty unpatentable through established prior art.

Original Patent Information

Patent Number	US 11,857,536
Title	Glucokinase activator for treating diabetes with renal impairment
Assignee(s)	HUA Medicine (Shanghai) Ltd.